Skip to main content
OpenTrials
Completed

NCT Number: NCT05988151

New Surgical Approach in Labioplasty

The data of patients who underwent labiaplasty + vaginoplasty between 2020 and 2022 by a single surgeon in our clinic were analyzed. Preoperative and postoperative FSFI (Female sexual function index) questionnaire scores were used to compare the results of the classical surgical approach and the new surgical approach technique designed according to the Fibonacci ratio in the early postoperative period such as operating time, bleeding amount, etc.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Batman Training and Research Hospital

Batman, 72000, Turkey (Türkiye)

About this study

The data of patients who underwent labiaplasty + vaginoplasty between 2020-2022 for reasons such as vaginal laxity, personal hygiene problems, recurrent vaginal infections were analyzed retrospectively. The data of the patients who underwent fibonacci ratio, which is a new surgical approach technique( by Okuyan E. M.D), and the patients who underwent classical surgical technique were taken from their files and retrospectively analyzed. Data including age, body mass index, number of live births, preoperative FSFI, FGSIS and postoperative one month FSFI (Female sexual function index) and FGSIS (The Female Genital Self-Image Scale) scores were recorded and compared between both groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • No history of any disease
  • The presence of at least 2 of the reasons such as dislike of cosmetic appearance, vaginal abundance, personal hygiene disorder, difficulty in wearing underwear.
  • Body mass index between 15-25
  • Informed consent has been obtained for the new surgical approach technique.
  • Not taking any medication continuously
  • Willing to participate in the study.

Exclusion criteria

  • Absence of at least 2 of the reasons such as dislike of cosmetic appearance, vaginal

abundance, personal hygiene disorder, difficulty in wearing underwear.

  • History of continuous medication, alcohol and/or smoking.
  • History of chronic diseases (Asthma, Diabetes mellitus, Cardiac disease, Psychiatric disease etc.)
  • Body mass index outside the range of 15-25.
  • Not wanting to be included in the study or wanting to leave the study after inclusion.

Treatment and study plan

New surgical approach

Other

Patients were included in the study after obtaining informed consent for the new surgical approach inspired by the Fibonacci ratio.

Primary outcomes

  1. To be able to standardize genital harmony using fibonacci ratio.

    Time frame: Postoperative 1 month

    To standardize the genital harmony with a holistic approach with the Fibonacci ratio with a purely mathematical ratio outside the existing classification systems (in contrast to Banwell, Motakeff classifications).

Secondary outcomes

  1. To adapt the fibonacci ratio to female genital cosmetic surgery

    Time frame: Postoperative 1 month

    To adapt the fibonacci ratio applied in breast and facial aesthetics to female genital aesthetic surgery procedures.

Sponsors and collaborators

Lead sponsor

Batman Training and Research Hospital

Other Gov

Registry information

Official study title

New Surgical Approach in Labioplasty: Inspired by the Fibonacci Ratio

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 14, 2023
Registry last updated
Oct 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.